Endari™ (L-glutamine) – New orphan drug approval
July 7, 2017 – The FDA announced the approval of Emmaus Medical’s Endari (L-glutamine), to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients ≥ 5 years of age.
Download PDF
